Michael A. Fortunato
Chief Accounting Officer · BioStem Technologies, Inc.
Individual
- 2026
- Sep 17, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Michael A. Fortunato's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $2.65B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael A. Fortunato?
Michael A. Fortunato is a corporate insider, tracked as Chief Accounting Officer of BioStem Technologies, Inc. (BSEM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael A. Fortunato submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
